We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+33.13%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.84B
AUM Growth
+$507M
(+38%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
8.45%
Top 10 Holdings %
Top 10 Hldgs %
76.86%
Holding
43
New
2
Increased
2
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBX
MBX Biosciences
MBX
|
+$82.7M |
| 2 |
ZBIO
Zenas BioPharma
ZBIO
|
+$47M |
| 3 |
TEM
Tempus AI
TEM
|
+$38M |
| 4 |
IMA
ImageneBio Inc
IMA
|
+$50.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYND
Mynd.ai
MYND
|
+$7M |
| 2 |
TUYA
Tuya Inc
TUYA
|
+$5.58M |
| 3 |
AFMD
Affimed
AFMD
|
+$4 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.15% |
| 2 | Consumer Staples | 5.57% |
| 3 | Technology | 3.35% |
| 4 | Communication Services | 0.56% |
| 5 | Industrials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BuzzFeed
BZFD
$94.1M
| $10.2M | 0.56% |
3,833,473
| – | – |
|
|
RGLS
27
DELISTED
Regulus Therapeutics
RGLS
| $10.2M | 0.55% |
6,467,802
| – | – |
|
28
X4 Pharmaceuticals
XFOR
$425M
| $10M | 0.55% |
499,560
| – | – |
|
29
Champions Oncology
CSBR
$73.2M
| $8.35M | 0.45% |
1,713,720
| – | – |
|
|
OKUR
30
OnKure Therapeutics
OKUR
$163M
| $8.14M | 0.44% |
478,549
| – | – |
|
|
DM
31
DELISTED
Desktop Metal, Inc.
DM
| $6.72M | 0.37% |
1,439,892
| – | – |
|
32
Sagimet Biosciences
SGMT
$545M
| $5.54M | 0.3% |
2,000,275
| – | – |
|
|
SYBX
33
DELISTED
Synlogic
SYBX
| $4.35M | 0.24% |
2,922,772
| – | – |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| $4M | 0.22% |
6,147,260
| – | – |
|
35
Lexicon Pharmaceuticals
LXRX
$1.07B
| $3.74M | 0.2% |
2,382,286
| – | – |
|
36
Marker Therapeutics
MRKR
$18.7M
| $3.02M | 0.16% |
1,071,428
| – | – |
|
|
IVA
37
Inventiva
IVA
$1.15B
| $2.75M | 0.15% |
1,462,586
| – | – |
|
|
AFMD
38
DELISTED
Affimed
AFMD
| $1.49M | 0.08% |
442,648
-1
| -0% | -$4 |
|
|
IMA
39
ImageneBio Inc
IMA
$62.4M
| $1.04M | 0.06% |
50,005
+2,501
| +5% | +$50.6K |
|
40
Senti Biosciences Holdings
SNTI
$10.9M
| $1M | 0.05% |
442,615
| – | – |
|
41
Wheels Up
UP
$196M
| $257K | 0.01% |
5,306
| – | – |
|
|
MYND
42
Mynd.ai
MYND
$17.4M
| $165K | 0.01% |
206,208
-3,436,503
| -94% | -$7M |
|
|
TUYA
43
Tuya Inc
TUYA
$1.08B
| – | – |
-3,260,976
| Closed | -$5.58M |
|
Similar funds
NM
SLF
CGH
CIP
GD
DF
HHAM
MAM
NEA Management Company's Q3 2024 Portfolio in Review
As of Q3 2024, NEA Management Company held 43 positions worth $1.84B, up 38% from $1.33B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
NEA Management Company deployed $155M of net new capital in Q3 2024, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was MBX Biosciences: 3,614,486 shares worth $93.9M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Mynd.ai, an estimated $7M trimmed.
- NEA Management Company's largest Q3 2024 buy was MBX Biosciences: 3,614,486 shares worth $93.9M.
- NEA Management Company added most to Tempus AI in Q3 2024, an estimated $38M increase.
- NEA Management Company's biggest Q3 2024 reduction was Mynd.ai, cutting an estimated $7M.
- NEA Management Company fully exited Tuya Inc in Q3 2024, selling an estimated $5.58M.
- NEA Management Company's ten largest holdings make up 77% of its $1.84B portfolio in Q3 2024.
- NEA Management Company opened 2 new positions and closed 1 in Q3 2024.
- NEA Management Company's portfolio value rose 38% quarter-over-quarter to $1.84B.
Based on NEA Management Company's 13F filing for Q3 2024, filed 14 Nov 2024.